See Street Research during your Free Trial
Clear This Search
Kala Pharmaceuticals opens at $16.60, IPO priced at $15 per share
Kala Pharmaceuticals indicated to open at $16.50, IPO priced at $15
The deal range was…
The deal range was $14.00-$16.00. JPMorgan, BofA/Merrill and Wells Fargo acted as joint book running managers for the offering.